These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2805343)

  • 1. Clinical evaluation of serum thyroglobulin measurement using a commercial kit in the diagnosis of recurrent thyroid cancer.
    Tokmakjian SD; Haines DS; Driedger AA
    Clin Biochem; 1989 Oct; 22(5):395-9. PubMed ID: 2805343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
    Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
    Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
    Weightman DR; Mallick UK; Fenwick JD; Perros P
    Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical importance of anti-thyroglobulin auto-antibodies in patients with differentiated thyroid carcinoma: comparison with 99mTc-MIBI scans.
    Küçük ON; Aras G; Kulak HA; Ibiş E
    Nucl Med Commun; 2006 Nov; 27(11):873-6. PubMed ID: 17021427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of serum thyroglobulin after surgery for thyroid carcinoma.
    Hall FT; Beasley NJ; Eski SJ; Witterick IJ; Walfish PG; Freeman JL
    Laryngoscope; 2003 Jan; 113(1):77-81. PubMed ID: 12514386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroglobulin may be undetectable in the serum of patients with metastatic disease secondary to differentiated thyroid carcinoma. Follow-up of differentiated thyroid carcinoma.
    Grant S; Luttrell B; Reeve T; Wiseman J; Wilmshurst E; Stiel J; Donohoe D; Cooper R; Bridgman M
    Cancer; 1984 Oct; 54(8):1625-8. PubMed ID: 6478402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients.
    Duren M; Siperstein AE; Shen W; Duh QY; Morita E; Clark OH
    Surgery; 1999 Jul; 126(1):13-9. PubMed ID: 10418587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of Detectable Antithyroglobulin Antibodies Below the Reference Limit (Borderline) in Patients with Papillary Thyroid Carcinoma with Undetectable Serum Thyroglobulin and Normal Neck Ultrasonography After Ablation: A Prospective Study.
    Côrtes MCS; Rosario PW; Oliveira LFF; Calsolari MR
    Thyroid; 2018 Feb; 28(2):229-235. PubMed ID: 29325506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-levothyroxine measurement of thyroglobulin is not a reliable test for the follow-up of patients at high risk for remnant/recurrent differentiated thyroid carcinoma.
    Gholamrezanezhad A; Saghari M; Mirpour S; Beiki D; Tarbiat A; Javan S; Abdollahzadeh J
    Endokrynol Pol; 2007; 58(2):100-4. PubMed ID: 17578824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels.
    Pellegriti G; Scollo C; Regalbuto C; Attard M; Marozzi P; Vermiglio F; Violi MA; Cianci M; Vigneri R; Pezzino V; Squatrito S
    Clin Endocrinol (Oxf); 2003 May; 58(5):556-61. PubMed ID: 12699436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three immunoassay kits for serum thyroglobulin in patients with thyroid cancer.
    Dai J; Dent W; Atkinson JW; Cox JG; Dembinski TC
    Clin Biochem; 1996 Oct; 29(5):461-5. PubMed ID: 8884068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance between thyroglobulin antibody assays.
    Taylor KP; Parkington D; Bradbury S; Simpson HL; Jefferies SJ; Halsall DJ
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):367-9. PubMed ID: 21502198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood.
    Ringel MD; Ladenson PW; Levine MA
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4435-42. PubMed ID: 9851791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time quantitative PCR measurement of thyroglobulin mRNA in peripheral blood of thyroid cancer patients and healthy subjects.
    Li D; Butt A; Clarke S; Swaminathana R
    Ann N Y Acad Sci; 2004 Jun; 1022():147-51. PubMed ID: 15251954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
    Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
    Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.
    Golger A; Fridman TR; Eski S; Witterick IJ; Freeman JL; Walfish PG
    J Endocrinol Invest; 2003 Oct; 26(10):1023-31. PubMed ID: 14759077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma.
    Whitley RJ; Ain KB
    Clin Lab Med; 2004 Mar; 24(1):29-47. PubMed ID: 15157556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.
    Ozata M; Suzuki S; Miyamoto T; Liu RT; Fierro-Renoy F; DeGroot LJ
    J Clin Endocrinol Metab; 1994 Jul; 79(1):98-105. PubMed ID: 8027262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients.
    Baudin E; Do Cao C; Cailleux AF; Leboulleux S; Travagli JP; Schlumberger M
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1107-11. PubMed ID: 12629092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.